You Don't Have to Just 'Push Through' Menopause — Here's What Actually Helps

Menopause is natural, but suffering is optional. Learn about the 'window of opportunity' for hormone therapy, why OB-GYNs prefer the patch over the pill, and non-hormonal alternatives.

Written by Herexa Team

5 min read

You've probably heard it more times than you can count: "It's just menopause. Every woman goes through it."

Which is technically true. But "every woman goes through it" doesn't mean you have to suffer through it — waking up at 3am drenched in sweat, struggling to concentrate at work, or feeling like your body became someone else's overnight.

Key Takeaway

Menopause is natural. Suffering is optional.

What's the Difference Between Perimenopause and Menopause?

These two words get used interchangeably all the time, but they mean different things.

The most recent data suggests the average woman experiences hot flashes for 7 to 10 years — not just a few months, as many women are told.

What Symptoms Are We Actually Talking About?

Menopause affects far more than just hot flashes. Here's what estrogen decline can cause:

Vasomotor symptoms: Hot flashes, night sweats, sudden waves of heat. These affect about 75 to 80 percent of menopausal women and can be severe enough to disrupt sleep, work, and daily life.
Genitourinary changes: Vaginal dryness, pain during sex, urinary urgency, recurrent UTIs. Unlike hot flashes, these symptoms don't improve on their own over time. Without treatment, they typically get worse.
Sleep disturbances: Often tied to night sweats, but also caused by hormonal changes independently. Poor sleep compounds every other symptom.
Mood and cognitive changes: Irritability, anxiety, difficulty concentrating, and depression. Perimenopause is a genuinely higher-risk window for mood disorders.
Joint pain and skin changes: Estrogen supports collagen and joint health. Its decline can cause aching joints and noticeably drier, thinner skin.

What Are the Treatment Options?

Hormone Therapy — Still the Most Effective Option Available

Let's clear something up first. Hormone therapy got a lot of bad press after the Women's Health Initiative (WHI) study in 2002, and many women — and unfortunately, some doctors — still operate from that fear.

What the current science says:

Menopause treatment isn’t one-size-fits-all—today’s science supports personalized options, from hormone therapy to non-hormonal solutions, based on your needs.

Hormone therapy remains the most effective treatment available for vasomotor symptoms, reducing hot flash frequency by 75 to 90 percent.

The Patch vs. the Pill — And Why It Matters

When you swallow a pill, it travels through your digestive system and is absorbed via the liver. This "first-pass effect" triggers clotting proteins in the liver, increasing blood clot risk. In contrast, the estrogen patch delivers estradiol through your skin directly into the bloodstream, bypassing the liver entirely and avoiding increased clot risk.

What About Progesterone?

If you still have your uterus, estrogen alone isn't enough. Adding a progestogen provides endometrial protection. Micronized progesterone (Prometrium) is the body-identical form with the best safety profile, compared to older synthetic progestins used in early studies.

What If You Don't Want Hormones?

Hormone therapy isn't right for everyone. FDA-approved non-hormonal options like Fezolinetant (Veozah) can reduce hot flash frequency by ~60%. Other alternatives include SSRIs, gabapentin, and CBT.

Is Hormone Therapy Right for You?

Take our 2-minute clinical assessment to see if you qualify for personalized relief led by board-certified OB-GYN Dr. Amir Shay.

Start Consultation

Evidence-based answers to common questions about perimenopause and Hormone Therapy (HT).

Don't see your question listed below? Check our

Help Center

Hormone Therapy (HT), formerly known as HRT, replaces the estrogen (and sometimes progestogen) that the body stops producing naturally during the menopause transition. It is the most effective treatment for hot flashes, night sweats, and vaginal dryness.

The benefit-risk ratio is most favorable for healthy women under 60 who are within 10 years of their last period and have no history of breast cancer, heart disease, or blood clots.

Women with unexplained vaginal bleeding, history of breast cancer, active DVT/PE or clotting disorder, severe liver disease, recent heart attack or stroke, or uncontrolled hypertension (BP >160/100) are not eligible for telehealth-only care and should be evaluated in-person.

Estrogen alone causes the uterine lining to thicken, which increases endometrial cancer risk. Progestogen (like micronized progesterone) protects the lining and neutralizes this risk.